Latest Breaking News On - Reza halse - Page 1 : comparemela.com

Share this article Share this article COPENHAGEN, Denmark, April 29, 2021 /PRNewswire/  Adcendo, a biotech company developing antibody-drug conjugates (ADCs) for the treatment of cancers, today announced the successful closing of a EUR 51 million (US$ 62 million) Series A financing. The investment was led by Novo Seeds, the early-stage investment and company creation team of Novo Holdings, and Ysios Capital, along with RA Capital Management, HealthCap and Gilde Healthcare. The company was initially incubated and funded at the BioInnovation Institute (BII).  The new financing, which is the largest Series A financing for a Danish biotech company, will be used to establish a pipeline of ADCs directed at novel cancer targets and to bring the lead program targeting the novel cancer target uPARAP/Endo180 to proof of concept in patients.

Niels behrendtSantaris pharmaReza halseJohn haurumJeroen bakkerChristoffer nielsenLars henning engelholmLars engelholmBioinnovation instituteFinsen laboratory of rigshospitaletFinsen laboratoryUniversity of copenhagenBioinnovation institute creation house programCreation house programNovo nordisk foundationNovo holdings